Glassman Wealth Services’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-77
Closed -$9.55K 1335
2023
Q4
$9.55K Hold
77
﹤0.01% 900
2023
Q3
$10.2K Buy
+77
New +$11.9K ﹤0.01% 845
2023
Q1
Sell
-77
Closed -$16.7K 1961
2022
Q4
$16.7K Hold
77
﹤0.01% 705
2022
Q3
$30K Hold
77
0.01% 515
2022
Q2
$33K Hold
77
0.01% 488
2022
Q1
$46K Buy
+77
New +$57.2K 0.01% 422
2021
Q4
Sell
-46
Closed -$177K 1830
2021
Q3
$177K Hold
46
0.04% 167
2021
Q2
$133K Buy
46
+4
+10% +$9.45K 0.03% 193
2021
Q1
$83K Hold
42
0.02% 248
2020
Q4
$40K Sell
42
-73
-63% -$62.4K 0.01% 372
2020
Q3
$92K Hold
115
0.03% 211
2020
Q2
$109K Hold
115
0.03% 160
2020
Q1
$102K Buy
115
+41
+55% +$33.5K 0.04% 159
2019
Q4
$40K Buy
74
+3
+4% +$1.25K 0.02% 284
2019
Q3
$31K Buy
71
+25
+54% +$11.4K 0.01% 305
2019
Q2
$24K Buy
46
+29
+171% +$15.3K 0.01% 344
2019
Q1
$8K Hold
17
﹤0.01% 483
2018
Q4
$7K Buy
+17
New +$8.32K ﹤0.01% 400

Other funds holding PAVM

Glassman Wealth Services's PAVM Position: Q1 2024 in Review

Glassman Wealth Services sold out of PAVmed (PAVM) in Q1 2024, closing a stake of 77 shares — an estimated $9.55K sold.

Glassman Wealth Services first reported a position in PAVM in Q4 2018 and held it in 18 quarters. The position peaked at $177K in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2024.

  • Glassman Wealth Services reported no remaining PAVmed position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 77 PAVmed shares in Q1 2024, an estimated $9.55K.
  • Glassman Wealth Services first reported a position in PAVmed in Q4 2018 and held it in 18 quarters.
  • Glassman Wealth Services's PAVmed position peaked at $177K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.